Application

Benchling & uniQure: Bringing a gene therapy pioneer from paper to the cloud

Benchling

Aug 24, 2021

Abstract

uniQure is rapidly advancing a pipeline of AAV-based gene therapies to treat patients with hemophilia, Huntington’s disease, and other severe genetic diseases, but they needed a digital solution that could track their gene therapy workflows end-to-end and enable international collaboration. Learn how Benchling was able to move uniQure from paper to the cloud, improving R&D traceability and collaboration, and accelerating speed to innovation.

Application File

Benchling & uniQure Case Study.pdf

Comments

Be the first to comment.

Submit a Comment

First Name *

Last Name *

Email *

Comments *

Premier Sponsor
Benchling

Do you have a question about this Application?
Ask a scientist!

First Name *

Last Name *

Email *

Position *

Organization *

Question *

By clicking ‘Ask Your Question’ you agree to be contacted by the submitter (Benchling).